Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 206 citing Horton: Nateglinide alone and in combination with metformin improves glycemic control by.... (0.11 sec) 

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

- pharmyaring.com [PDF] 
SE Inzucchi - Jama, 2002 - Am Med Assoc
Context Care of patients with type 2 diabetes has been revolutionized throughout
the past several years—first, by the realization of the importance of tight
glycemic control in forestalling complications, and second, by the ...
Cited by 608 - Related articles - BL Direct - All 18 versions

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: …

- karolinskauniversitetssjukhuset.se [PDF] 
SR Salpeter, E Greyber, GA Pasternak, EE … - Archives of Internal Medicine, 2003 - archinte.highwire.org
Methods A comprehensive search was performed to identify all comparative trials
or observational cohort studies published between January 1, 1959, and March 31,
2002, that evaluated metformin therapy, alone or in combination with other ...
Cited by 322 - Related articles - BL Direct - All 16 versions

[PDF] Initial management of glycemia in type 2 diabetes mellitus


DM Nathan - N Engl j Med, 2002 - cme.nejm.org
After an overnight fast, an asymptomatic 45-year-old Hispanic man has a plasma
glucose level of 142 mg per deciliter (7.9 mmol per liter) on initial evaluation
and 139 mg per deciliter (7.7 mmol per liter) on reevaluation. Other than a ...
Cited by 244 - Related articles - Cached - BL Direct - All 17 versions

Fasting and postchallenge glycemia and cardiovascular disease risk


JB Meigs, DM Nathan, RB D'Agostino, PWF … - Diabetes care, 2002 - Am Diabetes Assoc
RESULTS—Mean subject age was 54 years, 54% were women, and previously
undiagnosed diabetes was present in 3.2% by FHG and 4.9% (164) by FHG or a 2hPG
≥11.1 mmol/l. Of these 164 subjects, 55 (33.5%) had 2hPG ≥11.1 without ...
Cited by 221 - Related articles - BL Direct - All 6 versions

Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: …


E Bonora, M Muggeo - Diabetologia, 2001 - Springer
Type II (non-insulin-dependent) diabetes mellitus is one of the most common
metabolic disorders. Epide- miological studies carried out in European countries
in the 1980s showed that about 3% of the general population had Type II ...
Cited by 190 - Related articles - BL Direct - All 3 versions

Clinical significance, pathogenesis, and management of postprandial hyperglycemia


JE Gerich - Archives of Internal Medicine, 2003 - archinte.highwire.org
It is well established that strict glycemic control (hemoglobin A 1c <7.0%) can
prevent the microvascular complications of diabetes mellitus. Recent studies
indicate that elevated plasma glucose concentrations are an independent and ...
Cited by 135 - Related articles - BL Direct - All 5 versions

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 …


Y Miyazaki, M Matsuda, RA DeFronzo - Diabetes Care, 2002 - Am Diabetes Assoc
RESULTS—Patients treated with 7.5 or 15 mg/day of pioglitazone had no change
in fasting plasma glucose (FPG) and fasting plasma insulin (FPI) concentrations
or in plasma glucose (PG) and insulin concentrations during the OGTT. ...
Cited by 133 - Related articles - BL Direct - All 6 versions

Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular …


RJ Heine, JM Dekker - Diabetologia, 2002 - Springer
Type II (non-insulin-dependent) diabetes mellitus is a very prevalent chronic
disease occurring in 2 to 4% of the general population in the Western world and
up to 20 to 30% in high risk populations [1]. Moreover, the global burden ...
Cited by 130 - Related articles - BL Direct - All 5 versions

Metformin: new understandings, new uses

- nursing2008.com
RS Hundal, SE Inzucchi - Drugs, 2003 - ingentaconnect.com
Metformin, a biguanide, has been available in the US for the treatment of type
Abstract 2 diabetes mellitus for nearly 8 years. Over this period of time, it
has become the most widely prescribed antihyperglycaemic agent. Its ...
Cited by 113 - Related articles - BL Direct - All 7 versions

Insulinotropic meglitinide analogues


A Dornhorst - The Lancet, 2001 - Elsevier
The loss of early-phase insulin secretion is an important and early event in the
natural history of type 2 diabetes. Because a normal pattern of insulin
secretion is essential for the effective control of postprandial ...
Cited by 106 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google